Browsing Tag
Fresenius Kabi
8 posts
Fresenius Kabi seeks FDA approval for innovative plasmapheresis software
Fresenius Kabi, a global healthcare company, has filed a 510(k) notification with the U.S. Food and Drug Administration…
Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts
Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous…
Caplin Point Laboratories subsidiary gets FDA final approval for Thiamine Hydrochloride Injection
Caplin Point Laboratories said that its subsidiary Caplin Steriles has secured final approval for its abbreviated new drug…
Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic
Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine…
Fresenius Kabi launches Levothyroxine Sodium Injection Solution in US
German pharma company Fresenius Kabi has launched its severe hypothyroidism treatment -Levothyroxine Sodium Injection Solution in 100 mcg…
Fresenius Kabi launches Methocarbamol Injection in US for acute musculoskeletal conditions
Fresenius Kabi, the global German healthcare company, has unveiled Methocarbamol Injection, USP in the United States, marking a…
Fresenius Kabi launches Omegaven for pediatric patients with parenteral nutrition-associated cholestasis in US
Fresenius Kabi, a prominent German pharmaceutical company, has introduced Omegaven (fish oil triglycerides) injectable emulsion in the United…
Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options
German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide…